跳转至内容
Merck
CN
  • Acute encephalopathy associated with intravenous immunoglobulin therapy.

Acute encephalopathy associated with intravenous immunoglobulin therapy.

AJNR. American journal of neuroradiology (2005-10-13)
Akihiko Wada, Rika Yoshida, Kazushige Oda, Eiji Fukuba, Nobue Uchida, Hajime Kitagaki
摘要

Intravenous immunoglobulin therapy is useful against various immune system disorders and viral infections. It is generally safe, and serious adverse reactions are uncommon. We report a rare case of acute encephalopathy following intravenous immunoglobulin therapy for human herpes virus 6 infection in a child. MR imaging findings suggest that the dominant causative mechanism of acute encephalopathy is cytotoxic edema, and the findings indicate 2 primary mechanisms. Reversibility of the restriction of water diffusion (low apparent diffusion coefficient value) on diffusion-weighted MR imaging suggests intramyelinic edema in the myelin sheath, and an increase of glutamate and glutamine complex peak on MR spectroscopy suggests excitotoxic injury to the neurons and astrocytes.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
L -谷氨酰胺 溶液, 200 mM, solution, sterile-filtered, BioXtra, suitable for cell culture
Sigma-Aldrich
L-谷氨酰胺, meets USP testing specifications, suitable for cell culture, 99.0-101.0%, from non-animal source
Sigma-Aldrich
L-谷氨酰胺, ReagentPlus®, ≥99% (HPLC)
SAFC
L-谷氨酰胺
Sigma-Aldrich
L-谷氨酰胺, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
L-谷氨酰胺, γ-irradiated, BioXtra, suitable for cell culture
Sigma-Aldrich
L-谷氨酰胺
Sigma-Aldrich
L -谷氨酰胺 溶液, 200 mM, Hybri-Max, sterile-filtered, suitable for hybridoma
Supelco
L-谷氨酰胺, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
L-谷氨酰胺, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
L-谷氨酰胺, Vetec, reagent grade, ≥99%